News Update

Sep 01, 2002
Pharmaceutical Executive
Patient advocates recently surprised pharmacists and manufacturers by convincing an FDA advisory panel to recommend increased government scrutiny of its voluntary patient information policy. FDA's Drug Safety and Risk Management Advisory Committee met in July to review the status of a private sector initiative for distributing medication information to patients obtaining prescriptions in pharmacies.
Sep 01, 2002
Pharmaceutical Executive
Many more high-risk patients could benefit from statin therapy than currently receive the cholesterol-lowering drugs, according to a major UK study set up by the Medical Research Council and the British Heart Foundation.
Sep 01, 2002
Pharmaceutical Executive
Instead of developing innovative therapies, pharma companies devote most of their resources to modifying existing medications, according to a report from the National Institute for Health Care Management Foundation (NIHCM).
Aug 01, 2002
Pharmaceutical Executive
In case anyone missed the recent wave of studies and reports documenting rising expenditures on medicines, Families USA weighed in with an analysis that further documents rising prices of medicines prescribed for the elderly. The report surfaced just before the US House of Representatives voted on a Medicare pharmacy benefit and was timed to influence that debate.
Aug 01, 2002
Pharmaceutical Executive
In response to concerns about the low level of patient participation in clinical trials, the British Medical Association has launched an internet resource aimed at encouraging more patients to take part. Aimed at healthcare professionals, the site explains how different types of trials are conducted and spells out their ethical and best practices requirements.
Aug 01, 2002
Pharmaceutical Executive
The United Kingdom's much-maligned National Institute for Clinical Excellence (NICE) could be in line for a shake-up if the recommendations of a House of Commons select committee go through.
Aug 01, 2002
Pharmaceutical Executive
Croatia's Pliva Pharmaceuticals is the first eastern European pharma company to make a US acquisition. Pliva paid $153 million for New Jersey-based Sobel Holdings,
Aug 01, 2002
Pharmaceutical Executive
When Pfizer gets in on a good thing, it isn't content to share. Two years ago the company initiated a semi-hostile takeover of Warner-Lambert to acquire full marketing rights to the hot-selling cholesterol treatment, Lipitor.
Aug 01, 2002
Pharmaceutical Executive
Activist protests about access to, and the price of, AIDS medicines marked the International AIDS conference in Barcelona. But they failed to overshadow the promising results of research into new ways of attacking the virus.
Aug 01, 2002
Pharmaceutical Executive
Donal Geaney and Tom Lynch, chairman/CEO and vice-chairman, respectively, of the troubled Irish pharma company Elan, resigned following intense pressure from investors.
native1_300x100
lorem ipsum